Insider Transactions

What CATALYST PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	5
Total trades	0	73

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 73 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Daly Richard J	President and CEO	Jul 15	Disposition to Issuer · D	−271,266	$31.50	−$8.54M	0
Andrews William T.	Chief Medical Officer	Jul 15	Disposition to Issuer · D	−2,309	$31.50	−$72.7K	0
Del Carmen Jeffrey	Chief Commercial Officer	Jul 15	Disposition to Issuer · D	−14,337	$31.50	−$452K	0
Denkhaus Donald A	Director	Jul 15	Disposition to Issuer · D	−498,773	$31.50	−$15.7M	0
Elsbernd Brian	Chief Legal Officer	Jul 15	Disposition to Issuer · D	−242,501	$31.50	−$7.64M	0
Harper Molly	Director	Jul 15	Disposition to Issuer · D	−3,694	$31.50	−$116K	0
Kalb Michael Wayne	Chief Financial Officer	Jul 15	Disposition to Issuer · D	−13,665	$31.50	−$430K	0
Mcenany Patrick J	Director	Jul 15	Disposition to Issuer · D	−4,171,559	$31.50	−$131M	0
Miller Steve	Chief Op. & Scientific Officer	Jul 15	Disposition to Issuer · D	−1,093,803	$31.50	−$34.5M	0
Russo Gregg	Chief HR Officer	Jul 15	Disposition to Issuer · D	−476	$31.50	−$15K	0
Sundaram Preethi	Chief Strategy Officer	Jul 15	Disposition to Issuer · D	−54,804	$31.50	−$1.73M	0
Thompson Tamar	Director	Jul 15	Disposition to Issuer · D	−3,773	$31.50	−$119K	0
Tierney David S	Director	Jul 15	Disposition to Issuer · D	−383,314	$31.50	−$12.1M	0
Andrews William T.	Chief Medical Officer	Jun 03	Withheld — tax / exercise cost · F	−743	—	—	2,309
Andrews William T.	Chief Medical Officer	Jun 03	Exercise / conversion · M	+3,052	—	—	3,052
Russo Gregg	Chief HR Officer	Feb 17	Withheld — tax / exercise cost · F	−211	—	—	476
Russo Gregg	Chief HR Officer	Feb 17	Exercise / conversion · M	+687	—	—	687
Daly Richard J	President and CEO	Jan 05	Withheld — tax / exercise cost · F	−10,577	—	—	271,266
Daly Richard J	President and CEO	Jan 05	Exercise / conversion · M	+42,105	—	—	281,843
Kalb Michael Wayne	Executive Vice President & CFO	Jan 05	Withheld — tax / exercise cost · F	−2,080	—	—	13,665

Page 1 of 36 · showing the 20 most recent Sign up free to view all 711 transactions and filter by insider →

Comments